Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26849 | 200 | 39.3 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PDCD4 | Author keyword | 80 | 62% | 42% | 83 |
| 2 | PROGRAMMED CELL DEATH 4 | Author keyword | 11 | 52% | 8% | 15 |
| 3 | PROGRAMMED CELL DEATH 4 PDCD4 | Author keyword | 9 | 83% | 3% | 5 |
| 4 | MA3 DOMAIN | Author keyword | 4 | 75% | 2% | 3 |
| 5 | PDCD4 GENE | Author keyword | 3 | 100% | 2% | 3 |
| 6 | GENE REGULAT SECT | Address | 1 | 11% | 6% | 12 |
| 7 | STABLY KNOCKDOWN | Author keyword | 1 | 100% | 1% | 2 |
| 8 | BIOMED POLYMER TISSUE ENGN | Address | 1 | 40% | 1% | 2 |
| 9 | CHEM GSC MS | Address | 1 | 40% | 1% | 2 |
| 10 | GEN ONCOL UNIT | Address | 1 | 27% | 2% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PDCD4 | 80 | 62% | 42% | 83 | Search PDCD4 | Search PDCD4 |
| 2 | PROGRAMMED CELL DEATH 4 | 11 | 52% | 8% | 15 | Search PROGRAMMED+CELL+DEATH+4 | Search PROGRAMMED+CELL+DEATH+4 |
| 3 | PROGRAMMED CELL DEATH 4 PDCD4 | 9 | 83% | 3% | 5 | Search PROGRAMMED+CELL+DEATH+4+PDCD4 | Search PROGRAMMED+CELL+DEATH+4+PDCD4 |
| 4 | MA3 DOMAIN | 4 | 75% | 2% | 3 | Search MA3+DOMAIN | Search MA3+DOMAIN |
| 5 | PDCD4 GENE | 3 | 100% | 2% | 3 | Search PDCD4+GENE | Search PDCD4+GENE |
| 6 | STABLY KNOCKDOWN | 1 | 100% | 1% | 2 | Search STABLY+KNOCKDOWN | Search STABLY+KNOCKDOWN |
| 7 | 9Z 11E 13 HYDROXY 9 11 OCTADECADIENOIC ACID | 1 | 50% | 1% | 1 | Search 9Z+11E+13+HYDROXY+9+11+OCTADECADIENOIC+ACID | Search 9Z+11E+13+HYDROXY+9+11+OCTADECADIENOIC+ACID |
| 8 | CELL SIGNAL PATHWAYS | 1 | 50% | 1% | 1 | Search CELL+SIGNAL+PATHWAYS | Search CELL+SIGNAL+PATHWAYS |
| 9 | CGA CHROMOGRANIN A | 1 | 50% | 1% | 1 | Search CGA+CHROMOGRANIN+A | Search CGA+CHROMOGRANIN+A |
| 10 | HUH7 HEPATOMA CELLS | 1 | 50% | 1% | 1 | Search HUH7+HEPATOMA+CELLS | Search HUH7+HEPATOMA+CELLS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRANSFORMATION SUPPRESSOR | 64 | 74% | 24% | 48 |
| 2 | PROGRAMMED CELL DEATH 4 | 23 | 62% | 12% | 24 |
| 3 | TUMOR SUPPRESSOR PDCD4 | 19 | 39% | 19% | 38 |
| 4 | SUPPRESSOR PDCD4 | 18 | 53% | 12% | 24 |
| 5 | PROTEIN PDCD4 | 17 | 100% | 4% | 8 |
| 6 | INITIATION FACTOR 4A | 10 | 22% | 20% | 40 |
| 7 | AP 1 TRANSACTIVATION | 10 | 29% | 15% | 29 |
| 8 | RECEPTOR U PAR | 6 | 80% | 2% | 4 |
| 9 | CELL DEATH 4 | 6 | 50% | 4% | 8 |
| 10 | MA 3 | 3 | 100% | 2% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation | 2009 | 121 | 64 | 73% |
| Pdcd4, a colon cancer prognostic that is regulated by a microRNA | 2010 | 53 | 64 | 38% |
| Programmed cell death protein 4 (pdcd4): A novel target for antineoplastic therapy? | 2003 | 43 | 32 | 50% |
| Targeting the eIF4A RNA helicase as an anti-neoplastic approach | 2015 | 0 | 164 | 21% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GENE REGULAT SECT | 1 | 11% | 6.0% | 12 |
| 2 | BIOMED POLYMER TISSUE ENGN | 1 | 40% | 1.0% | 2 |
| 3 | CHEM GSC MS | 1 | 40% | 1.0% | 2 |
| 4 | GEN ONCOL UNIT | 1 | 27% | 1.5% | 3 |
| 5 | EXPT SURG MOL ONCOL SOLID TUMORS | 1 | 16% | 2.0% | 4 |
| 6 | GERMAN CANC DKFZ HEIDELBERGMED MANNH | 1 | 50% | 0.5% | 1 |
| 7 | INTRAMURAL SUPPORT PROGRAMS | 1 | 50% | 0.5% | 1 |
| 8 | SAGA MED | 1 | 11% | 3.0% | 6 |
| 9 | CLIN UNIT GASTROINTESTINAL ENDOCRINOL | 1 | 12% | 2.5% | 5 |
| 10 | HEPATOL METAB | 1 | 19% | 1.5% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000139301 | ZBP 89//ZNF148//APOPTOSIS EFFECTOR GENES |
| 2 | 0.0000126759 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |
| 3 | 0.0000114227 | MICRORNA//MIR 21//MICRORNAS |
| 4 | 0.0000108623 | RNA HELICASE//DEAD BOX//DEAD BOX PROTEIN |
| 5 | 0.0000097172 | EIF4E//EIF 4E//CAPPING EFFICIENCY |
| 6 | 0.0000086478 | MGN 3//BIOBRAN//SOYBEAN BROTH |
| 7 | 0.0000083875 | AGR2//C44A//LYPD3 |
| 8 | 0.0000068408 | EXTRAVASCULAR MIGRATORY METASTASIS//ANGIOTROPISM//ANGIO TUMORAL COMPLEX |
| 9 | 0.0000057950 | HUMAN TOXICOL PROGRAM//PROGRAM FREE RAD RADIAT BIOL//BIOQUIM BIOQUIM BIOL MOL |
| 10 | 0.0000056674 | C MYB//B MYB//V MYB |